| Financial Year |
March 31 2023 |
| Monetary Funds |
103,695,350.80 |
| Held-for-trading Financial Assets |
39,041,991.67 |
| Notes Receivable |
274,979,406.24 |
| Accounts Receivable |
328,013,138.38 |
| Advances to Suppliers |
87,403,708.57 |
| Other Receivables |
4,750,227.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
231,649,599.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
134,296,248.84 |
| Total Current Assets |
1,215,790,275.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
461,505,250.77 |
| Under-construction Projects |
488,131,400.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
253,641,858.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
27,270,179.65 |
| Other Non-Current Assets |
618,346,423.07 |
| Sub-Total of Non-Current Assets |
1,848,895,112.97 |
| Total Assets |
3,064,685,388.36 |
| Short-Term Loans |
136,855,954.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
86,798,552.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,548,844.26 |
| Taxes Payable |
3,825,105.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,691,873.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
131,446,792.79 |
| Sub-Total of Current Liabilities |
431,279,036.66 |
| Long-term Loans |
10,698,092.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
87,778,092.00 |
| Total Liabilities |
519,057,128.66 |
| Paid-In Capital(Or Share Stock) |
466,802,614.00 |
| Capital Surplus |
792,738,185.20 |
| Surplus Reserve |
96,203,133.31 |
| LESS:Treasury Stock |
6,574,000.00 |
| Undistributed Profits |
1,192,918,713.07 |
| Minority Stockholder's Interest |
-136,088.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,545,764,347.94 |
| Owner's Equity（Stockholder's Equity） |
2,545,628,259.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,064,685,388.36 |
